Innospec Inc Valuation – Initial Coverage $IOSP

Benjamin Graham taught that Intelligent Investors must do a thorough fundamental analysis of investment opportunities to determine their intrinsic value and inherent risk.  This is best done by utilizing a systematic approach to analysis that will provide investors with a sense of how a specific company compares to another company or by reviewing the 10 Stocks for Using A Benjamin Graham Value Investing Strategy – December 2016.  By using the ModernGraham method one can review a company’s historical accomplishments and determine an intrinsic value that can be compared across industries.  What follows is a stock analysis showing a specific look at how Innospec Inc (IOSP) fares in the ModernGraham valuation model.

Company Profile (obtained from Google Finance): Innospec Inc. develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care and fragrance ingredients and other specialty chemicals. The Company operates in three segments: Fuel Specialties, Performance Chemicals and Octane Additives. The Company’s products are sold to oil and gas exploration and production companies, oil refineries, personal care and fragrance companies, and other chemical and industrial companies. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for the processes or products focused in the Personal Care, Polymers and Fragrance Ingredients markets. The Octane Additives segment produces tetra ethyl lead (TEL) and consists of sales of TEL for use in automotive gasoline, and provides services in its environmental remediation business.

IOSP Chart

IOSP data by YCharts

To read the details of this valuation, you must be logged in as a premium member. If you are not a premium member, please consider becoming one.

Premium members can view a full ModernGraham valuation of the company and have access to download a PDF version of the valuation for easy reference. Recent valuations of the components of the Dow Jones Industrial Average are available for free members, including this one of Microsoft Corporation.  In addition, here is a post detailing what can be found within each individual company’s valuation.


Downloadable PDF version of this valuation:

ModernGraham Valuation of IOSP – December 2016

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $1,659,856,456 Fail
2. Sufficiently Strong Financial Condition Current Ratio > 2 3.01 Pass
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Fail
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 487.24% Pass
6. Moderate PEmg Ratio PEmg < 20 19.15 Pass
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 2.65 Fail
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 3.01 Pass
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 0.45 Pass
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Pass

Stage 2: Determination of Intrinsic Value

EPSmg $3.68
MG Growth Estimate 11.14%
MG Value $113.19
Opinion Undervalued
MG Grade B-
MG Value based on 3% Growth $53.34
MG Value based on 0% Growth $31.27
Market Implied Growth Rate 5.33%
Current Price $70.45
% of Intrinsic Value 62.24%

Innospec Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, poor dividend history, and the high PB ratio. The Enterprising Investor has no initial concerns. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.

As for a valuation, the company appears to be Undervalued after growing its EPSmg (normalized earnings) from $2.11 in 2012 to an estimated $3.68 for 2016. This level of demonstrated earnings growth outpaces the market’s implied estimate of 5.33% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value above the price.

At the time of valuation, further research into Innospec Inc. revealed the company was trading above its Graham Number of $44.72. The company pays a dividend of $0.64 per share, for a yield of 0.9% Its PEmg (price over earnings per share – ModernGraham) was 19.15, which was below the industry average of 22.46, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $3.59.

Innospec Inc. performs fairly well in the ModernGraham grading system, scoring a B-.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) $3.59
Graham Number $44.72
PEmg 19.15
Current Ratio 3.01
PB Ratio 2.65
Current Dividend $0.64
Dividend Yield 0.91%
Number of Consecutive Years of Dividend Growth 4


Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 9/1/2016
Total Current Assets $479,200,000
Total Current Liabilities $159,000,000
Long-Term Debt $143,000,000
Total Assets $1,043,300,000
Intangible Assets $417,900,000
Total Liabilities $391,400,000
Shares Outstanding (Diluted Average) 24,476,000

Earnings Per Share History

Next Fiscal Year Estimate $3.27
Dec2015 $4.86
Dec2014 $3.38
Dec2013 $3.22
Dec2012 $2.81
Dec2011 $1.92
Dec2010 $2.97
Dec2009 $0.26
Dec2008 $0.51
Dec2007 $1.19
Dec2006 $0.45
Dec2005 -$5.00
Dec2004 $0.24
Dec2003 $2.06
Dec2002 $2.08
Dec2001 $0.23
Dec2000 $0.71
Dec1999 $1.53
Dec1998 $2.43

Earnings Per Share – ModernGraham History

Next Fiscal Year Estimate $3.68
Dec2015 $3.67
Dec2014 $3.00
Dec2013 $2.62
Dec2012 $2.11
Dec2011 $1.63
Dec2010 $1.35
Dec2009 $0.19
Dec2008 -$0.07
Dec2007 -$0.31
Dec2006 -$0.72
Dec2005 -$0.90
Dec2004 $1.12
Dec2003 $1.48
Dec2002 $1.26
Dec2001 $0.89
Dec2000 $1.13

Recommended Reading:

Other ModernGraham posts about the company

None.  This is the first time ModernGraham has covered the company.

Other ModernGraham posts about related companies

Albemarle Corporation Valuation – August 2016 $ALB
Air Products & Chemicals Inc Valuation – August 2016 $APD
Ashland Inc Valuation – July 2016 $ASH
FMC Corporation Valuation – July 2016 $FMC
Eastman Chemical Company Valuation – July 2016 $EMN
Dow Chemical Co Valuation – July 2016 $DOW
Olin Corporation Valuation – June 2016 $OLN
LyondellBasell Industries Valuation – June 2016 $LYB
Praxair Inc Valuation – June 2016 $PX
Albemarle Corp Valuation – February 2016 $ALB


The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.